Evidence map›Paper›PMID 34065168›Full record

ArticleInternational journal of molecular sciences2021

A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.

Antonio J López-Gambero, Cristina Rosell-Valle, Dina Medina-Vera, Juan Antonio Navarro, Antonio Vargas, Patricia Rivera, Carlos Sanjuan, Fernando Rodríguez de Fonseca, Juan Suárez

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Behaviour Hallmarks in Alzheimer's Disease 5xFAD Mouse Model.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Hypothalamic Regulation of Obesity.International journal of molecular sciences · 2021
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Antonio J López-GamberoInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.ORCID 0000-0001-7716-9056
Cristina Rosell-ValleInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.ORCID 0000-0001-9545-0976
Dina Medina-VeraInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.ORCID 0000-0002-0342-1287
Juan Antonio NavarroInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.ORCID 0000-0003-3089-0983
Antonio VargasInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.
Patricia RiveraInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.
Carlos SanjuanEURONUTRA S.L, Parque Tecnológico de Andalucía, 29590 Campanillas, Spain.ORCID 0000-0003-3505-0481
Fernando Rodríguez de FonsecaInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.ORCID 0000-0002-4516-5795
Juan SuárezInstituto de investigación Biomédica de Málaga-IBIMA, 29010 Málaga, Spain.ORCID 0000-0001-5254-9802
Hospital Regional Universitario de Málaga · ESInstituto de Investigación Biomédica de Málaga · ES

Funding

Consejería de Transformación Económica, Industria, Conocimiento y Universidades. Junta de Andalucía P18-TP-5194H2020 European Research Council EULACH16/T010131Instituto de Salud Carlos III CP19/00068Instituto de Salud Carlos III CPII17/00024Instituto de Salud Carlos III FI20/00227Instituto de Salud Carlos III IFI18/00042Instituto de Salud Carlos III PI19/00343Instituto de Salud Carlos III PI19/01577Ministerio de Economía, Industria y Competitividad, Gobierno de España RTC-2016-4983-1Ministerio de Sanidad, Consumo y Bienestar Social PNSD 2019/040Ministerio de Sanidad, Consumo y Bienestar Social PNSD 2020/048
6 · The paper itself

Abstract

Increasing evidence links metabolic disorders with neurodegenerative processes including Alzheimer's disease (AD). Late AD is associated with amyloid (Aβ) plaque accumulation, neuroinflammation, and central insulin resistance. Here, a humanized AD model, the 5xFAD mouse model, was used to further explore food intake, energy expenditure, neuroinflammation, and neuroendocrine signaling in the hypothalamus. Experiments were performed on 6-month-old male and female full transgenic (Tg

Indexed as

Alzheimer DiseaseAmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloidogenic ProteinsAnimalsBrainDisease Models, AnimalEnergy MetabolismFemaleGastric Inhibitory PolypeptideGhrelinGlucagon-Like Peptide 1HypothalamusInsulinMaleAmyloidAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAmyloidogenic ProteinsGastric Inhibitory PolypeptideGhrelinGlucagon-Like Peptide 1InsulinResistin5xFADAlzheimer’s diseaseenergy expenditurehypothalamusinsulin signalingneuroinflammation

Identifiers

PMID34065168
PMCPMC8161294
OpenAlexW3163686960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.